Stock Analysis of Ambrx Biopharma Inc ADR (AMAM) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code AMAM
Close 28.00
Change 0.0200 / 0.071 %
Volume 1436.55 K
Vol Change 419496 / 41.25 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Excellent Stability


Fundamental View of Ambrx Biopharma Inc ADR
PE (TTM)

-16463.91

Very Poor
Price / Book

12104.51

Very Poor
Price / Sales

256407

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

1772.10 M

Enterprise Value

1772.10 M

ROA (TTM)

-63.43

Very Poor
ROE (TTM)

-73.52

Very Poor
Net Margin (TTM)

-1557.39

Very Poor
Revenue

44.70 %

4093.00 K
Net Profit

14.03 %

-67056.00 K
Debt to Equity

0

Excellent
Altman Z Score

Indecisive
Quick Ratio

0

Poor
Cash Ratio

0

Poor


Highs/Lows of Ambrx Biopharma Inc ADR
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week27.94 0.215 % 1.54 % 28.027.9306-Mar-2401-Mar-24
Two Week27.7 1.08 % 3.42 % 28.0327.926-Feb-2428-Feb-24
One Month27.78 0.792 % 5.60 % 28.0327.5126-Feb-2420-Feb-24
Three Month12.03 132.75 % 5.95 % 28.1511.7410-Jan-2412-Dec-23
Six Months13.25 111.32 % 17.48 % 28.156.5610-Jan-2423-Oct-23
One year12.54 123.29 % 27.52 % 28.156.5610-Jan-2423-Oct-23
Two year4.51 520.84 % 29.70 % 28.150.3810-Jan-2408-Dec-22


Technical View of Ambrx Biopharma Inc ADR
RSI

82.20

Mild Bearish
MACD

0.664

Strong Bearish
ADX

55.72

Bullish
Super Trend

27.67

Mild Bullish
Williams %R

-5.77

Mild Bearish
CCI

93.36

Neutral


EMA 5

27.97

Mild Bullish
EMA 15

27.85

Bullish
EMA 50

24.87

Bullish
EMA 100

20.90

Bullish
SMA 100

18.20

Bullish
SMA 200

15.99

Bullish
SMA 5 / 20

27.97 / 27.86

Bullish
SMA 15 / 50

27.88 / 25.33

Bullish
SMA 50 / 200

25.33 / 15.99

Strong Bullish




Charts of Ambrx Biopharma Inc ADR


Returns of Ambrx Biopharma Inc ADR with Peers
Period / StockAMAMNAMSPTGXLMAT
1 Week0.215%-6.25%8.89%3.05%
1 Mth0.792%0.200%20.22%24.44%
3 Mth132.75%-3.04%9.59%25.42%
6mth111.32%112.59%82.87%47.71%
1 Year123.29%67.42%16.75%23.00%
2 Year520.84%104.37%257.03%72.30%
5 Years--184.37%185.17%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Ambrx Biopharma Inc ADR with Peers
Ratio / StockAMAMNAMSPTGXLMAT
PE-16463.91-16.535502.8951.97
P/B12104.5111.682609.166.07
ROA-63.43-58.9843.1710.13
ROE-73.52-70.6747.4111.68
Debt To Equity00.00020.00340.0083
Revenue4093.00 K
44.70 % 		14090.00 K
85.55 % 		60000.00 K
125.73 % 		185555 K
14.79 %
Net Income-67056.00 K
14.03 % 		-176937.00 K
126.69 % 		-140484.00 K
10.28 % 		27267.00 K
32.13 %


Technicals of Ambrx Biopharma Inc ADR with Peers
Technical / StockAMAMNAMSPTGXLMAT-
ADX55.7218.1423.6134.86
CMF0.064-0.1890.03880.252
MFI81.3832.6677.8279.98
RSI82.2041.9165.8076.19
MACD Abv SignalFalseFalseTrueTrue
Price Above 50 MATrueFalseTrueTrue-
Price Above 200 MATrueTrueTrueTrue-


About : Ambrx Biopharma Inc. American Depositary Shares

Address : 10975 North Torrey Pines Road, La Jolla, CA, United States, 92037
Tel : 858 875 2400
URL : https://ambrx.com
Code : AMAM, ISIN : US02290A1025, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 18_Jun_2021
Employee Count : 87

Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California. As of March 7, 2024, Ambrx Biopharma Inc. operates as a subsidiary of Johnson & Johnson.


Note : All Data Generated at the End of Trading Hours (EOD Data)